GLP-1 weight loss injections, which have revolutionized obesity treatment with around 100 million users worldwide, are facing challenges in accessibility on the NHS due to strict eligibility criteria and high costs, despite their efficacy highlighted by clinical trials showing substantial weight loss in patients. #WeightLoss #ObesityCrisis #GLP1 #GB #US #DK


